全文获取类型
收费全文 | 21993篇 |
免费 | 5984篇 |
国内免费 | 126篇 |
专业分类
耳鼻咽喉 | 638篇 |
儿科学 | 655篇 |
妇产科学 | 721篇 |
基础医学 | 414篇 |
口腔科学 | 2655篇 |
临床医学 | 4348篇 |
内科学 | 5194篇 |
皮肤病学 | 490篇 |
神经病学 | 1938篇 |
特种医学 | 995篇 |
外科学 | 3855篇 |
综合类 | 104篇 |
现状与发展 | 12篇 |
一般理论 | 1篇 |
预防医学 | 2823篇 |
眼科学 | 355篇 |
药学 | 247篇 |
中国医学 | 10篇 |
肿瘤学 | 2648篇 |
出版年
2024年 | 135篇 |
2023年 | 1091篇 |
2022年 | 373篇 |
2021年 | 658篇 |
2020年 | 1229篇 |
2019年 | 510篇 |
2018年 | 1338篇 |
2017年 | 1304篇 |
2016年 | 1521篇 |
2015年 | 1588篇 |
2014年 | 2003篇 |
2013年 | 2411篇 |
2012年 | 814篇 |
2011年 | 789篇 |
2010年 | 1399篇 |
2009年 | 1967篇 |
2008年 | 799篇 |
2007年 | 552篇 |
2006年 | 703篇 |
2005年 | 525篇 |
2004年 | 383篇 |
2003年 | 351篇 |
2002年 | 292篇 |
2001年 | 403篇 |
2000年 | 290篇 |
1999年 | 400篇 |
1998年 | 519篇 |
1997年 | 488篇 |
1996年 | 535篇 |
1995年 | 393篇 |
1994年 | 304篇 |
1993年 | 261篇 |
1992年 | 182篇 |
1991年 | 162篇 |
1990年 | 148篇 |
1989年 | 151篇 |
1988年 | 126篇 |
1987年 | 124篇 |
1986年 | 105篇 |
1985年 | 99篇 |
1984年 | 77篇 |
1983年 | 89篇 |
1982年 | 84篇 |
1981年 | 69篇 |
1980年 | 47篇 |
1979年 | 33篇 |
1978年 | 36篇 |
1977年 | 45篇 |
1976年 | 33篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
4.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
5.
Uday Yanamandra Prateek Deo Kamal Kant Sahu Ram Vasudevan Nampoothiri Nalini Gupta Anusree Prabhakaran Deb Prasad Dhibhar Alka Khadwal Gaurav Prakash Man Upadesh Singh Sachdeva Deepesh Lad Neelam Varma Subhash Varma Pankaj Malhotra 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):183-189.e1
Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献6.
7.
8.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
9.
10.